Pillar Biosciences at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Pillar Biosciences brings 3 presentations to AMP 2026 in Seattle, and exhibits at Booth 928, MR8. Its sessions centre on rapid sequencing panels a local laboratory can run itself, across myeloid and lymphoid malignancies and liquid biopsy. Another covers biomarker testing closer to the patient in advanced breast cancer.
| Organization | AMP 2026 Attendance |
|---|---|
Pillar Biosciences Natick, MA | |
Next-generation sequencing kits for cancer testing built on SLIMamp and PiVAT technologies, in research-use and in vitro diagnostic formats. | Booth Exhibiting at Booth 928, MR8 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 10:00am–10:50am Rapid NGS That Scales: Clinical Implementation of oncoReveal® Myeloid NGS on the MiSeq i100 Bringing a myeloid sequencing panel in house on a benchtop sequencer, reaching roughly three-day turnaround across 200 samples. Workshop Wed, Nov 11 8:00am–8:50am Evaluation and Analytical Validation of a Rapid NGS Panel to Evaluate Lymphoid Malignancies Validating a rapid sequencing panel for lymphoid cancers, with wider gene coverage and shorter turnaround in a hospital lab. Workshop Wed, Nov 11 9:00am–9:50am Bringing Liquid Biopsy Closer to Patients: Rapid Local NGS Testing for Biomarker Assessment in Advanced Breast Cancer Running ctDNA testing locally for advanced breast cancer cuts turnaround, raising questions of validation, interpretation and quality control. |
Instantly find 20 buyers from Pillar Biosciences
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction